Cellular Origins

Raised $40M in a Series A round, announced 9 December 2025.

Round

Over-subscribed Series A to grow the commercial team, add unit operations and build global manufacturing infrastructure.

Amount
$40M
Stage
Series A
Announced
9 December 2025
Lead
Johnson & Johnson Innovation - JJDC
Other investors
Highland Europe, BGF, NYBC Ventures, TTP Group
Use of funds
Over-subscribed Series A to grow the commercial team, add unit operations and build global manufacturing infrastructure.
Checked
Amount and date matched across 2 press sources

Company

Robotic Constellation platform automating cell and gene therapy manufacturing

Based in
Cambridge, United Kingdom
Sector
Health
Website
cellularorigins.com ↗

Sources and links

Sources
Cellular Origins raises $40M Series A european-biotechnology.com
Cellular Origins raises $40M Series A startuprise.co.uk
Website
cellularorigins.com ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost